U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07173868) titled 'FDG PET-CT in Advanced Breast Cancer' on Aug. 20.
Brief Summary: This study is a prospective cohort study comparing metabolic response evaluation by F-18 FDG PET-CT versus conventional imaging for outcome stratification in patients with advanced breast cancer receiving first-line systemic therapy.
Study Start Date: July 25
Study Type: OBSERVATIONAL
Condition:
Histologically Confirmed Metastatic or Locally Advanced Breast Cancer With no Radical Topical Treatment Available
If There is Liver Metastasis, Which the Researcher Believes Will be Difficult to Evaluate the Response Accurately With Bone Metastasis or CT
Recruitment Statu...